access+affordability

An Edmonton family is pushing for the province to cover the costs of a multi-million dollar drug that could change their son’s life.

Remdesivir isn’t a miracle drug.

For starters, the drug has not been approved for use in Canada.

The Africa Union calls for an “equitable and timely distribution” of a Covid-19 vaccine by partnering with the COVID-19 Vaccine Global Access, or Covax.

However, the price was swiftly criticized.

CNBC's Meg Tirrell breaks down how Gilead decided on its pricing for its coronavirus drug remdesivir.

Gilead Sciences Inc. detailed its pricing plans for Covid-19 drug remdesivir, saying it will charge U.S. hospitals $3,120 for a typical patient with commercial insurance.

For all governments in the developed world, including the U.S. government’s Medicaid program and the Department of Veterans Affairs, Gilead will charge $2,340 for a five-day course.

Gilead’s pricing decision is consequential because it sets a precedent for how much future Covid-19 treatments might cost.

Researchers are looking at how to ensure equitable distribution of a COVID-19 vaccine for countries most vulnerable to the coronavirus outbreak.

In the race for a coronavirus vaccine governments around the world are throwing billions of dollars at pharma firms to be first to come up with a solution.

A fair price for Gilead's coronavirus drug, remdesivir, likely should not exceed $2,800 for a course of treatment.

A baby may need what may be one of the most expensive medicines in the world in order to survive.

Demand is soaring for a cheap and widely used steroid that has been hailed as a potential breakthrough in the treatment of patients with severe Covid-19.

Evidence given to parliamentary committee sparks new calls to develop national capability to manufacture medicines and key supplies.